AHR vs CTRE

Key Takeaways

• AHR and CTRE are both healthcare-focused real estate investment trusts (REITs) riding strong demographic tailwinds in senior housing and skilled nursing, yet they pursue distinctly different operating and capital allocation strategies.
• AHR delivered exceptional same-store net operating income (NOI) growth of 14.2% for full-year 2025, driven by its operating portfolio segments, while raising 2026 NFFO (Normalized Funds From Operations) guidance to $1.99–$2.05 per share.
• CTRE closed a record $1.8 billion in investments during 2025 at a blended stabilized yield of 8.6%, expanded into the United Kingdom, and maintains an ultra-conservative balance sheet with net debt-to-EBITDA (earnings before interest, taxes, depreciation, and amortization) of just 0.7x.
• Both companies have added senior housing operating portfolios (SHOP) to their business mix, signaling a shared conviction in the long-term care demand-supply imbalance.
• Investors seeking higher organic growth and operational leverage may find AHR compelling, while those prioritizing dividend yield, balance sheet strength, and external acquisition momentum may favor CTRE.
• Despite operating in the same sector, the two REITs diverge sharply on valuation multiples, dividend policy, and growth drivers — making a side-by-side comparison especially instructive.

Introduction

Healthcare REITs have emerged as one of the most closely watched real estate subsectors, fueled by an aging population, constrained new supply of senior housing and skilled nursing facilities, and improving occupancy trends. Within this space, American Healthcare REIT (AHR) and CareTrust REIT (CTRE) stand out as two California-based companies executing distinct strategies to capture value from the same macro narrative. This comparison is designed for investors and traders evaluating which of these two healthcare real estate names may better align with their portfolio objectives — whether they prioritize operational growth, income generation, balance sheet resilience, or a blend of all three.

AHR Overview and Recent Performance

American Healthcare REIT (AHR) is a self-managed REIT headquartered in Irvine, California, with a diversified portfolio spanning senior housing operating properties (SHOP), integrated senior health campuses (ISHC), outpatient medical buildings, and triple-net leased properties. Unlike many healthcare REITs that function primarily as passive landlords, AHR takes an active operating approach through its SHOP and ISHC segments, partnering with regional operators to manage properties directly.

In recent months, AHR has sustained remarkable momentum. For full-year 2025, the company reported total portfolio same-store NOI growth of 14.2%, led by its SHOP segment at 25.2% and ISHC at 18.4%. Normalized FFO (NFFO) per share reached $1.72, representing 22% year-over-year growth. The company deployed over $950 million in acquisitions during 2025, expanding its footprint across high-quality senior housing and long-term care assets. Its balance sheet has continued to improve, with net debt-to-annualized adjusted EBITDA declining to 3.4x. Looking ahead, management has guided for 2026 NFFO of $1.99 to $2.05 per share and total portfolio same-store NOI growth of 7% to 11%. The stock has appreciated approximately 55% over the past year and has been trading near its all-time highs, reflecting strong investor conviction.

CTRE Overview and Recent Performance

CareTrust REIT (CTRE), based in Dana Point, California, is a self-administered REIT that owns, acquires, and leases skilled nursing facilities, senior housing, and other healthcare-related properties across the United States and the United Kingdom. Historically known as a triple-net lease REIT — where tenants bear most property-level costs — CTRE has recently broadened its model with a landmark acquisition of Care REIT plc in May 2025, opening a UK care homes platform, and the establishment of a SHOP segment for direct operating exposure.

CTRE's recent performance has been defined by extraordinary external growth. The company closed approximately $1.8 billion in investments during full-year 2025 at a blended stabilized yield of 8.6%, an annual record. Full-year normalized FFO reached $1.76 per share, up 17% year-over-year, while net income attributable to CareTrust surged 96% to $320.5 million. The balance sheet remains a standout feature: net debt-to-annualized normalized run-rate EBITDA stood at just 0.7x as of year-end 2025, with full availability on a $1.2 billion revolving credit facility and no debt maturities before 2028. For 2026, management guided normalized FFO to a range of $1.90 to $1.95 per share, implying roughly 9% growth at the midpoint. CTRE's quarterly dividend of $0.335 per share translates to an annualized yield above 3.6%, supported by a conservative payout ratio.

Trending AI Robots

In a market environment where stock selection demands rapid synthesis of technical signals, fundamental data, and shifting sentiment, AI-powered trading tools are increasingly part of the institutional and retail investor toolkit. Tickeron's Trending AI Robots page curates a select group of AI trading bots from a universe of hundreds — each bot designed to trade specific tickers with distinct strategies, timeframes, and risk parameters. Only the bots demonstrating the strongest alignment with prevailing market conditions earn placement in this featured section. Performance metrics across these bots span a wide range, with some showcasing annualized returns well above broad market benchmarks, depending on strategy type and market regime. Whether a trader favors short-term swing trading, trend-following, or pattern-recognition approaches, the Trending AI Robots section offers a filtered view of what is currently working. Explore the curated selection of Trending AI Robots to see which strategies are resonating in today's market.

Head-to-Head Comparison

Business Model and Revenue Mix. AHR operates a blended model with significant direct operating exposure through its SHOP and ISHC segments, meaning it captures both rental income and operating profits — but also absorbs operating costs and occupancy risk. CTRE has historically been a pure triple-net lease REIT, collecting predictable rent checks with minimal operating cost exposure. However, with its recent SHOP launch and UK expansion, CTRE is gradually diversifying toward a more balanced model.

Growth Drivers. AHR's growth has been overwhelmingly organic, powered by occupancy gains, rate increases, and expense discipline within its operating portfolio. CTRE's growth, by contrast, has been predominantly external — acquiring properties and entire platforms at scale. The $1.8 billion deployed by CTRE in 2025 dwarfs AHR's $950 million in acquisitions during the same period, though AHR's investments are concentrated in higher-growth operating assets.

Balance Sheet and Risk. CTRE maintains one of the strongest balance sheets in the healthcare REIT sector, with net leverage of 0.7x, zero revolver borrowings, and substantial liquidity. AHR's net debt-to-EBITDA of 3.4x is healthy by REIT standards but represents meaningfully higher leverage. CTRE's fortress balance sheet provides a bigger cushion during downturns and greater capacity to fund opportunistic acquisitions.

Dividend and Valuation. CTRE offers a quarterly dividend of $0.335 per share (annualized yield of approximately 3.6%), while AHR pays $0.25 per quarter (approximately 1.74% yield). On valuation, AHR trades at a significantly higher price-to-earnings multiple — roughly 97 times trailing earnings versus CTRE's approximately 27 times — reflecting the market's premium for AHR's superior organic growth trajectory. AHR's market capitalization of approximately $11.9 billion also modestly exceeds CTRE's $10.2 billion.

Market Sentiment. Both stocks have delivered strong returns over the past year — AHR up roughly 55% and CTRE up roughly 44% — and both are trading near their 52-week highs. Sentiment in the healthcare REIT space remains broadly positive, supported by demographic trends and constrained new construction, though interest rate expectations and Medicare/Medicaid policy uncertainty remain sector-wide risks.

Tickeron AI Verdict

Based on observable trend consistency, balance sheet quality, and the breadth of growth catalysts, Tickeron's AI-driven analysis would likely express a slight preference for CTRE in the current environment. While AHR has delivered undeniably superior organic same-store growth, its elevated valuation multiple and higher operational leverage introduce greater sensitivity to any slowdown in the senior housing cycle. CTRE's combination of a nearly debt-free balance sheet, a $500 million investment pipeline, a higher dividend yield backed by a conservative payout ratio, and incremental upside from its new UK and SHOP platforms provides a more balanced risk-reward profile. This assessment is probabilistic and reflects current observable data rather than any definitive forecast. Both companies are well-positioned within a sector enjoying powerful secular tailwinds, and the relative attractiveness of each may shift as market conditions evolve.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations